Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 4, 1997, Pages 451-454

  Persi, L ^a   Dupin, O ^b   Arnaud, B ^c   Trinquand, C ^b   Michel, F B ^a   Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b Laboratoire Chauvin   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

allergen threshold dose; conjunctival provocation test; index of reactivity; visual analog scale

Indexed keywords

ALLERGEN; CROMOGLYCATE DISODIUM; EYE DROPS; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; LEVOCABASTINE; MEQUITAZINE; PLACEBO;

ADULT; ALLERGIC CONJUNCTIVITIS; ANAMNESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GRASS POLLEN; HUMAN; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT SURVEY; SLIT LAMP; TOPICAL DRUG ADMINISTRATION;

EID: 0030943964     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb01028.x     Document Type: Short Survey

References (18)

1. Proud D, Sweet J, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990;85:896-905.
2. Abelson MB, Allansmith MR. Histamine and the eye. In: Silverstein AM, O'Conner GR, editors. International Symposium on the Immunology and Immunopathology of the Eye, 1978. San Francisco, CA: Masson, 1979:362-4.
3. Ciprandi G, Buscaglia S, Cerqueti PM, Canonica GW. Drug treatment of allergic conjunctivitis. A review of the evidence. Drugs 1992;43:154-76.
4. Abelson MB, Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol 1994;4:91-101.
5. Hugonot L, Hugonot R, Beaumont D. A double-blind comparison of terfenadine and mequitazine in the symptomatic treatment of acute pollinosis. J Int Med Res 1986;14:124-30.
6. 1-antagonist mequitazine: studies on performance and visual function. Eur J Clin Pharmacol 1983;25:563-6.
7. Pukander JS, Karma PH, Penttila MA, Perala ME, Ylitalo P, Kataja MJ. Mequitazine and dexchlorpheniramine in perennial rhinitis. A double-blind cross-over placebo-controlled study. Rhinology 1990;28:249-56.
8. Beaumont G, Dobbins S, Latta D, McMillin WP. Mequitazine in the treatment of hay fever. Br J Clin Pract 1990; 44:183-8.
9. Skassa-Brociek W, Bousquet J, Montes F, et al. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1988;81:725-30.
10. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. Arch Ophthalmol 1990;108:84-8.
11. Ciprandi G, Buscaglia S, Pesce GP, Marchesi E, Canonica GW. Protective effect of loratadine on specific conjunctival provocation test. Int Arch Allergy Appl Immunol 1991;96: 344-7.
12. Moller C, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984;39:37-41.
13. Aichane A, Campbell A, Chanal I, et al. Precision of conjunctival provocation tests in right and left eyes. J Allergy Clin Immunol 1993;92:49-55.
14. Spilker B. Guide to clinical trials. New York: Raven Press, 1991:162-3.
15. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983;34:234-9.
16. Nordic Council of Medicines. Guidelines for the registration of allergen preparations. Uppsala: Nordic Council of Medicines, 1980.
17. Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol 1992;110:381-7.
18. 1 antagonist, in a conjunctival provocation test with allergens. J Allergy Clin Immunol 1988;82:590-4.